[1]
Zaenglein, A. and Del Rosso, J. 2018. An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S33. DOI:https://doi.org/10.25251/skin.2.supp.32.